<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Impact of Approved Drug Labeling on Chronic Opioid Therapy; Public Hearing; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Impact of Approved Drug Labeling on Chronic Opioid Therapy; Public Hearing; Request for Comments</h1>
    <p class="timestamp">Published: 2012-12-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-30516</p>
    <p><strong>Publication Date:</strong> 2012-12-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/12/19/2012-30516/impact-of-approved-drug-labeling-on-chronic-opioid-therapy-public-hearing-request-for-comments">https://www.federalregister.gov/documents/2012/12/19/2012-30516/impact-of-approved-drug-labeling-on-chronic-opioid-therapy-public-hearing-request-for-comments</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-30516</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
